Font Size: a A A

Study On Targeting Oncolytic Adenovirus That TRAIL Linked Smac With IETD For Cancer Therapy

Posted on:2011-05-26Degree:MasterType:Thesis
Country:ChinaCandidate:Y TanFull Text:PDF
GTID:2154330332457548Subject:Biochemistry and Molecular Biology
Abstract/Summary:PDF Full Text Request
The causes of cancer are often associated with multiple genes mutation. Effective gene therapy for cancer should be multiple therapeutic genes of multitarget suppression. In theory, a dual genes combination strategy simultaneously targeting multiple defective genes would be more effective and complete than single-gene strategy. But the most critical issue is the lack of an ideal connexon, which can express dual genes effectively. Several strategies have been described to co-express two or more genes by IRES or self-cleaving peptide FMDV 2A. Since the expression level of transgenes often dramatically affects the therapeutic efficacy. The large size and the imbalance expression of IRESes, and the low self-cleave efficiency of FMDV 2A limit their utility in dual genes therapy. So IETD connexon was introduced for an alternative strategy to guarantee a reliable co-expression.TRAIL and Smac were connected by IETD, and then join in ZD55 system to construct Targeting dual gene-virus ZD55-TRAIL-(IETD)-Smac. When ZD55-TRAIL-(IETD)-Smac infect tumor cells, precursor of caspase-8 can be activated by stress reaction due to duplication of viruses. Activated caspase-8 can recognize and cleave IETD peptide, then generate solitary and competent TRAIL and Smac protein. At the same time, competent TRAIL can further activated caspase-8 precursor, then apoptosis was cascade amplification. TRAIL and Smac have complementary action on co-inhibit tumor cells.Western blot showed that the expression levels of TRAIL and Smac protein from Targeting dual gene-virus ZD55-TRAIL-(IETD)-Smac were nearly equal to these proteins from single-gene virus. MTT assays and CPE experiments showed that ZD55-TRAIL-(IETD)-Smac exhibited higher antitumor effect than ZD55,ZD55-TRAIL,ZD55-Smac and ZD55-TRAIL plus ZD55-Smac, at the same time, it was proved to be very safe to normal cells. Furthermore, ZD55-TRAIL-(IETD)-Smac can dramatically inhibit the volume of the NCI-H460 lung carcinoma in nude mice compared to other viruses.Compare to single gene-virotherapy or single gene-virotherapy alliance, Targeting dual gene-virus ZD55-TRAIL-(IETD)-Smac attain better antitumor effect.This study set up a solid foundation for exploring more effective dual gene-virotherapy.
Keywords/Search Tags:TRAIL, Smac, IETD, Targeting dual gene-virotherapy
PDF Full Text Request
Related items